Somatic estrogen receptor α mutations that induce dimerization promote receptor activity and breast cancer proliferation. 2024

Seema Irani, and Wuwei Tan, and Qing Li, and Weiyi Toy, and Catherine Jones, and Mayur Gadiya, and Antonio Marra, and John A Katzenellenbogen, and Kathryn E Carlson, and Benita S Katzenellenbogen, and Mostafa Karimi, and Ramya Segu Rajappachetty, and Isabella S Del Priore, and Jorge S Reis-Filho, and Yang Shen, and Sarat Chandarlapaty
Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

Physiologic activation of estrogen receptor α (ERα) is mediated by estradiol (E2) binding in the ligand-binding pocket of the receptor, repositioning helix 12 (H12) to facilitate binding of coactivator proteins in the unoccupied coactivator binding groove. In breast cancer, activation of ERα is often observed through point mutations that lead to the same H12 repositioning in the absence of E2. Through expanded genetic sequencing of breast cancer patients, we identified a collection of mutations located far from H12 but nonetheless capable of promoting E2-independent transcription and breast cancer cell growth. Using machine learning and computational structure analyses, this set of mutants was inferred to act distinctly from the H12-repositioning mutants and instead was associated with conformational changes across the ERα dimer interface. Through both in vitro and in-cell assays of full-length ERα protein and isolated ligand-binding domain, we found that these mutants promoted ERα dimerization, stability, and nuclear localization. Point mutations that selectively disrupted dimerization abrogated E2-independent transcriptional activity of these dimer-promoting mutants. The results reveal a distinct mechanism for activation of ERα function through enforced receptor dimerization and suggest dimer disruption as a potential therapeutic strategy to treat ER-dependent cancers.

UI MeSH Term Description Entries
D008024 Ligands A molecule that binds to another molecule, used especially to refer to a small molecule that binds specifically to a larger molecule, e.g., an antigen binding to an antibody, a hormone or neurotransmitter binding to a receptor, or a substrate or allosteric effector binding to an enzyme. Ligands are also molecules that donate or accept a pair of electrons to form a coordinate covalent bond with the central metal atom of a coordination complex. (From Dorland, 27th ed) Ligand
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D004958 Estradiol The 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl group at 3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian estrogenic steroids. 17 beta-Estradiol,Estradiol-17 beta,Oestradiol,17 beta-Oestradiol,Aerodiol,Delestrogen,Estrace,Estraderm TTS,Estradiol Anhydrous,Estradiol Hemihydrate,Estradiol Hemihydrate, (17 alpha)-Isomer,Estradiol Monohydrate,Estradiol Valerate,Estradiol Valeriante,Estradiol, (+-)-Isomer,Estradiol, (-)-Isomer,Estradiol, (16 alpha,17 alpha)-Isomer,Estradiol, (16 alpha,17 beta)-Isomer,Estradiol, (17-alpha)-Isomer,Estradiol, (8 alpha,17 beta)-(+-)-Isomer,Estradiol, (8 alpha,17 beta)-Isomer,Estradiol, (9 beta,17 alpha)-Isomer,Estradiol, (9 beta,17 beta)-Isomer,Estradiol, Monosodium Salt,Estradiol, Sodium Salt,Estradiol-17 alpha,Estradiol-17beta,Ovocyclin,Progynon-Depot,Progynova,Vivelle,17 beta Estradiol,17 beta Oestradiol,Estradiol 17 alpha,Estradiol 17 beta,Estradiol 17beta,Progynon Depot
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D047628 Estrogen Receptor alpha One of the ESTROGEN RECEPTORS that has marked affinity for ESTRADIOL. Its expression and function differs from, and in some ways opposes, ESTROGEN RECEPTOR BETA. ERalpha,Estradiol Receptor alpha,Estrogen Receptor 1,Estrogen Receptors alpha,Receptor alpha, Estrogen,Receptor alpha, Estradiol,alpha, Estradiol Receptor
D049109 Cell Proliferation All of the processes involved in increasing CELL NUMBER including CELL DIVISION. Cell Growth in Number,Cellular Proliferation,Cell Multiplication,Cell Number Growth,Growth, Cell Number,Multiplication, Cell,Number Growth, Cell,Proliferation, Cell,Proliferation, Cellular
D019281 Dimerization The process by which two molecules of the same chemical composition form a condensation product or polymer. Dimerizations

Related Publications

Seema Irani, and Wuwei Tan, and Qing Li, and Weiyi Toy, and Catherine Jones, and Mayur Gadiya, and Antonio Marra, and John A Katzenellenbogen, and Kathryn E Carlson, and Benita S Katzenellenbogen, and Mostafa Karimi, and Ramya Segu Rajappachetty, and Isabella S Del Priore, and Jorge S Reis-Filho, and Yang Shen, and Sarat Chandarlapaty
June 2012, Molecular cancer research : MCR,
Seema Irani, and Wuwei Tan, and Qing Li, and Weiyi Toy, and Catherine Jones, and Mayur Gadiya, and Antonio Marra, and John A Katzenellenbogen, and Kathryn E Carlson, and Benita S Katzenellenbogen, and Mostafa Karimi, and Ramya Segu Rajappachetty, and Isabella S Del Priore, and Jorge S Reis-Filho, and Yang Shen, and Sarat Chandarlapaty
September 2017, Oncotarget,
Seema Irani, and Wuwei Tan, and Qing Li, and Weiyi Toy, and Catherine Jones, and Mayur Gadiya, and Antonio Marra, and John A Katzenellenbogen, and Kathryn E Carlson, and Benita S Katzenellenbogen, and Mostafa Karimi, and Ramya Segu Rajappachetty, and Isabella S Del Priore, and Jorge S Reis-Filho, and Yang Shen, and Sarat Chandarlapaty
May 2021, Cell death & disease,
Seema Irani, and Wuwei Tan, and Qing Li, and Weiyi Toy, and Catherine Jones, and Mayur Gadiya, and Antonio Marra, and John A Katzenellenbogen, and Kathryn E Carlson, and Benita S Katzenellenbogen, and Mostafa Karimi, and Ramya Segu Rajappachetty, and Isabella S Del Priore, and Jorge S Reis-Filho, and Yang Shen, and Sarat Chandarlapaty
September 2022, JNCI cancer spectrum,
Seema Irani, and Wuwei Tan, and Qing Li, and Weiyi Toy, and Catherine Jones, and Mayur Gadiya, and Antonio Marra, and John A Katzenellenbogen, and Kathryn E Carlson, and Benita S Katzenellenbogen, and Mostafa Karimi, and Ramya Segu Rajappachetty, and Isabella S Del Priore, and Jorge S Reis-Filho, and Yang Shen, and Sarat Chandarlapaty
October 2021, Cell death & disease,
Seema Irani, and Wuwei Tan, and Qing Li, and Weiyi Toy, and Catherine Jones, and Mayur Gadiya, and Antonio Marra, and John A Katzenellenbogen, and Kathryn E Carlson, and Benita S Katzenellenbogen, and Mostafa Karimi, and Ramya Segu Rajappachetty, and Isabella S Del Priore, and Jorge S Reis-Filho, and Yang Shen, and Sarat Chandarlapaty
September 2020, Neoplasia (New York, N.Y.),
Seema Irani, and Wuwei Tan, and Qing Li, and Weiyi Toy, and Catherine Jones, and Mayur Gadiya, and Antonio Marra, and John A Katzenellenbogen, and Kathryn E Carlson, and Benita S Katzenellenbogen, and Mostafa Karimi, and Ramya Segu Rajappachetty, and Isabella S Del Priore, and Jorge S Reis-Filho, and Yang Shen, and Sarat Chandarlapaty
April 2014, Clinical cancer research : an official journal of the American Association for Cancer Research,
Seema Irani, and Wuwei Tan, and Qing Li, and Weiyi Toy, and Catherine Jones, and Mayur Gadiya, and Antonio Marra, and John A Katzenellenbogen, and Kathryn E Carlson, and Benita S Katzenellenbogen, and Mostafa Karimi, and Ramya Segu Rajappachetty, and Isabella S Del Priore, and Jorge S Reis-Filho, and Yang Shen, and Sarat Chandarlapaty
November 2016, Trends in endocrinology and metabolism: TEM,
Seema Irani, and Wuwei Tan, and Qing Li, and Weiyi Toy, and Catherine Jones, and Mayur Gadiya, and Antonio Marra, and John A Katzenellenbogen, and Kathryn E Carlson, and Benita S Katzenellenbogen, and Mostafa Karimi, and Ramya Segu Rajappachetty, and Isabella S Del Priore, and Jorge S Reis-Filho, and Yang Shen, and Sarat Chandarlapaty
January 1998, Biochemical Society symposium,
Seema Irani, and Wuwei Tan, and Qing Li, and Weiyi Toy, and Catherine Jones, and Mayur Gadiya, and Antonio Marra, and John A Katzenellenbogen, and Kathryn E Carlson, and Benita S Katzenellenbogen, and Mostafa Karimi, and Ramya Segu Rajappachetty, and Isabella S Del Priore, and Jorge S Reis-Filho, and Yang Shen, and Sarat Chandarlapaty
February 2014, Breast cancer research and treatment,
Copied contents to your clipboard!